With the development of newer meshes and approaches to hernia repair, it is currently difcult to evaluate their performances while considering the patients’ perspective. The aim of the study was to assess the clinical outcomes and quality of life consequences of abdominal hernia repairs performed in Italy using Phasix and Phasix ST meshes through the analysis of real-world data to support the choice of new generation biosynthetic meshes. An observational, prospective, multicentre study was conducted in 10 Italian clinical centres from May 2015 to February 2018 and in 15 Italian clinical centres from March 2018 to May 2019. The evaluation focused on patients with VHWG grade II–III who underwent primary ventral hernia repair or incisional hernia intervention with a follow-up of at least 18 months. Primary endpoints included complications’ rates, and secondary outcomes focused on patient quality of life as measured by the EuroQol questionnaire. Seventy-fve patients were analysed. The main complications were: 1.3% infected mesh removal, 4.0% superfcial infection requiring procedural intervention, 0% deep/organ infection, 8.0% recurrence, 5.3% reintervention, and 6.7% drained seroma. The mean quality of life utility values ranged from 0.768 (baseline) to 0.967 (36 months). To date, Phasix meshes have proven to be suitable prostheses in preventing recurrence, with promising outcomes in terms of early and late complications and in improving patient quality of life.

Clinical outcomes and quality of life associated with the use of a biosynthetic mesh for complex ventral hernia repair: analysis of the “Italian Hernia Club” registry

Carla Rognoni
;
Ludovica Borsoi;Rosanna Tarricone;
2020

Abstract

With the development of newer meshes and approaches to hernia repair, it is currently difcult to evaluate their performances while considering the patients’ perspective. The aim of the study was to assess the clinical outcomes and quality of life consequences of abdominal hernia repairs performed in Italy using Phasix and Phasix ST meshes through the analysis of real-world data to support the choice of new generation biosynthetic meshes. An observational, prospective, multicentre study was conducted in 10 Italian clinical centres from May 2015 to February 2018 and in 15 Italian clinical centres from March 2018 to May 2019. The evaluation focused on patients with VHWG grade II–III who underwent primary ventral hernia repair or incisional hernia intervention with a follow-up of at least 18 months. Primary endpoints included complications’ rates, and secondary outcomes focused on patient quality of life as measured by the EuroQol questionnaire. Seventy-fve patients were analysed. The main complications were: 1.3% infected mesh removal, 4.0% superfcial infection requiring procedural intervention, 0% deep/organ infection, 8.0% recurrence, 5.3% reintervention, and 6.7% drained seroma. The mean quality of life utility values ranged from 0.768 (baseline) to 0.967 (36 months). To date, Phasix meshes have proven to be suitable prostheses in preventing recurrence, with promising outcomes in terms of early and late complications and in improving patient quality of life.
2020
Rognoni, Carla; Cuccurullo, Diego; Borsoi, Ludovica; Bonavina, Luigi; Asti, Emanuele; Crovella, Feliciano; Andrea Bassi, Uberto; Carbone, Gabriele; Guerini, Francesca; De Paolis, Paolo; Pessione, Silvia; Maria Greco, Vincenzo; Baccarini, Elisabetta; Soliani, Giorgio; Sagnelli, Carlo; Crovella, Clotilde; Trapani, Vincenzo; De Nisco, Carlo; Eugeni, Emilio; Zanzi, Federico; De Nicola, Enrico; Marioni, Antonio; Rosignoli, Alessandro; Silvestro, Roberto; Tarricone, Rosanna; Piccoli, Micaela
File in questo prodotto:
File Dimensione Formato  
Rognoni_et_al_2020.pdf

accesso aperto

Descrizione: Articolo
Tipologia: Pdf editoriale (Publisher's layout)
Licenza: Creative commons
Dimensione 897.08 kB
Formato Adobe PDF
897.08 kB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/11565/4028594
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 11
  • ???jsp.display-item.citation.isi??? 11
social impact